Methylation markers differentiate thyroid cancer from benign nodules.

about

Methylation markers differentiate thyroid cancer from benign nodules.

Item

http://www.wikidata.org/entity/Q47730789

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Methylation markers differentiate thyroid cancer from benign nodules.

@en

Methylation markers differentiate thyroid cancer from benign nodules.

@nl

type

Item

label

Methylation markers differentiate thyroid cancer from benign nodules.

@en

Methylation markers differentiate thyroid cancer from benign nodules.

@nl

prefLabel

Methylation markers differentiate thyroid cancer from benign nodules.

@en

Methylation markers differentiate thyroid cancer from benign nodules.

@nl

P1476

Methylation markers differentiate thyroid cancer from benign nodules.

@en

P2093

D Chitale

http://www.w3.org/2001/XMLSchema#string

G Divine

http://www.w3.org/2001/XMLSchema#string

J K Stephen

http://www.w3.org/2001/XMLSchema#string

J Merritt

http://www.w3.org/2001/XMLSchema#string

K M Chen

http://www.w3.org/2001/XMLSchema#string

M J Worsham

http://www.w3.org/2001/XMLSchema#string

P2860

Nidogen 1 and 2 gene promoters are aberrantly methylated in human gastrointestinal cancer

Prognostic significance of somatic RET oncogene mutations in sporadic medullary thyroid cancer: a 10-year follow-up study.

Association of aberrant methylation of tumor suppressor genes with tumor aggressiveness and BRAF mutation in papillary thyroid cancer

Structural and functional aspects of thyroid peroxidase

Nomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma: A Paradigm Shift to Reduce Overtreatment of Indolent Tumors

Induction of thyroid gene expression and radioiodine uptake in thyroid cancer cells by targeting major signaling pathways.

Aberrant CpG-island methylation has non-random and tumour-type-specific patterns.

Endothelin receptor type B gene promoter hypermethylation in salivary rinses is independently associated with risk of oral cavity cancer and premalignancy.

BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer.

Detection of promoter hypermethylation in salivary rinses as a biomarker for head and neck squamous cell carcinoma surveillance.

P2888

s40618-017-0702-2

P304

163-170

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40618-017-0702-2

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-06-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28612287

http://www.w3.org/2001/XMLSchema#string